NHC executive granted 1,342 restricted shares

FLATT BEN ANDERSON SR reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

FLATT BEN ANDERSON SR reported acquisition or exercise transactions in this Form 4 filing.

National Healthcare Corp senior vice president and CIO Ben Anderson Flatt Sr. received a grant of 1,342 shares of common stock on February 27, 2026. These are restricted shares granted at $0.00 per share, increasing his directly held common stock to 15,459.0547 shares after the award.

The restricted shares vest over three years, with 33 1/3% vesting on January 1, 2027, another 33 1/3% on January 1, 2028, and the final 33 1/3% on January 1, 2029. The filing also reports option holdings to purchase common stock, with several option positions listed as directly owned holdings.

Insider Trade Summary

Grant/Award: 1,342 shares

Grant/Award 5 txns

Insider FLATT BEN ANDERSON SR

Role Senior VP & CIO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,342	$0.00	$0.00
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--

Holdings After Transaction: Common Stock — 15,459.0547 shares (Direct); Option to Purchase Common Stock — 46,967 contracts (Direct)

Footnotes (1)

1. F1. Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NHC executive Ben Anderson Flatt Sr. report?

Ben Anderson Flatt Sr. reported receiving a grant of 1,342 shares of National Healthcare Corp common stock on February 27, 2026. The grant was recorded at $0.00 per share, reflecting a restricted stock award rather than an open-market purchase.

How many NHC shares does Ben Anderson Flatt Sr. hold after this grant?

Following the restricted stock grant, Ben Anderson Flatt Sr. directly holds 15,459.0547 shares of National Healthcare Corp common stock. This total reflects his ownership after adding the 1,342-share award reported in the Form 4 filing.

What are the vesting terms of the NHC restricted stock granted on February 27, 2026?

The 1,342 restricted shares of NHC vest over three years. 33 1/3% vest on January 1, 2027, another 33 1/3% on January 1, 2028, and the final 33 1/3% on January 1, 2029, subject to the award conditions.

Was the NHC Form 4 transaction a market purchase or sale of shares?

The Form 4 reports a grant or award acquisition of 1,342 restricted shares at $0.00 per share, not an open-market buy or sell. It represents equity compensation for the executive rather than a trading decision in the public market.

What option holdings did Ben Anderson Flatt Sr. report for NHC stock?

The filing lists several options to purchase NHC common stock as direct holdings. Following the reported date, option positions show 7,467, 12,000, 13,500, and 14,000 underlying shares in separate grants, indicating multiple outstanding option awards.

What role does Ben Anderson Flatt Sr. hold at National Healthcare Corp?

Ben Anderson Flatt Sr. is identified as Senior Vice President & Chief Information Officer of National Healthcare Corp. His Form 4 filing reflects equity compensation and existing option holdings associated with this executive leadership position at the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 04:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FLATT BEN ANDERSON SR

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TN 37130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP & CIO

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		1,342(1)	A	$0	15,459.0547	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$53.94							03/08/2024	03/08/2028	Common Stock	7,467		7,467	D
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	12,000		12,000	D
Option to Purchase Common Stock	$90.62							02/24/2026	02/24/2030	Common Stock	13,500		13,500	D
Option to Purchase Common Stock	$157.13							02/23/2027	02/23/2031	Common Stock	14,000		14,000	D

Explanation of Responses:

1. Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029.

	/s/ Ben Anderson Flatt	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.